These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1839900)

  • 1. Is dehydroepiandrosterone-sulphate a possible pathogenetic factor in osteopenia of patients with iron overload?
    Czink E; Horváth C; Malek AA; Siklósi G
    Haematologia (Budap); 1991; 24(1):47-56. PubMed ID: 1839900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcipenic osteopathy in transfusion hemosiderosis and idiopathic hemochromatosis].
    Czink E; Horváth C; Malek AA; Siklósi G
    Orv Hetil; 1991 Jun; 132(22):1187-92. PubMed ID: 1829804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteopenia in beta-thalassemia major].
    Brändle M; Galeazzi RL; Morant R; Oesterle M
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1867-74. PubMed ID: 8984599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypogonadism in idiopathic hemochromatosis].
    Foscolo G; De Menis E; Legovini P; Breda F; Monco A; Scaldaferri E; Conte N
    Minerva Endocrinol; 1989; 14(3):159-63. PubMed ID: 2516238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
    Lucidarme N; Ruiz JC; Czernichow P; Léger J
    J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: pilot study.
    Dunn PJ; Mahood CB; Speed JF; Jury DR
    N Z Med J; 1984 Nov; 97(768):805-8. PubMed ID: 6239112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitamin status and bone mineral density at patients with diseases of gastroenteric tract].
    Svetikova AA; Kodentsova VM; Vrzhesinskaia OA; Pereverzeva OG; Shakhovskaia AK; Kaganov BS
    Vopr Pitan; 2008; 77(2):32-5. PubMed ID: 18505096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased bone mineral density is common after autologous blood or marrow transplantation.
    Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
    Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
    Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The urinary elimination of cobalt 57 in iron-deficiency anemia and in iron-overload states].
    Weiller PJ; Roux G; Lam-My S; Boyer G; Bernard P; Mongin M
    Sem Hop; 1981 Mar 8-15; 57(9-10):461-5. PubMed ID: 6261388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral affection in asymptomatic adult patients with celiac disease.
    Mazure R; Vazquez H; Gonzalez D; Mautalen C; Pedreira S; Boerr L; Bai JC
    Am J Gastroenterol; 1994 Dec; 89(12):2130-4. PubMed ID: 7977227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I and mineral metabolism markers in children with idiopathic decrease in bone mass.
    Rusińska A; Chlebna-Sokół D
    Clin Chim Acta; 2006 Apr; 366(1-2):257-63. PubMed ID: 16330010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone sulphate (DS), dehydroepiandrosterone (D) and "free" dehydroepiandrosterone (FD) in the plasma of patients with thyroid diseases.
    Földes J; Fehér T; Fehér KG; Kollin E; Bodrogi L
    Horm Metab Res; 1983 Dec; 15(12):623-4. PubMed ID: 6229464
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pituitary investigations in idiopathic haemochromatosis (author's transl)].
    Bercovici JP; Darragon T; Caroff J; Le Roy J
    Sem Hop; 1979 Oct 18-25; 55(35-36):1606-12. PubMed ID: 231831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinopathies in transfusion-associated iron overload.
    Kim MK; Lee JW; Baek KH; Song KH; Kwon HS; Oh KW; Jang EH; Kang MI; Lee KW
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):271-7. PubMed ID: 22788934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.